GlaxoSmithKline plc (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 174   

Articles published

GSK 46.40 +0.02 (0.04%)
price chart
GlaxoSmithKline plc (ADR) (NYSE:GSK) Buys Stake in Aspen Pharmacare's ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) the U.K.'s biggest drugmaker, will take a stake in the Japanese subsidiary of Aspen Pharmacare Holdings Ltd.
Related articles »  
Analyst Update: Alcatel Lucent SA (ADR), AT&T Inc., and GlaxoSmithKline plc ...
Analysts are weighing in today on networking firm Alcatel Lucent SA (ADR) (NYSE:ALU), telecom issue AT&T Inc. (NYSE:T), and pharmaceutical power GlaxoSmithKline plc (ADR) (NYSE:GSK). Here's a quick look at today's brokerage notes on ALU, T, and ...
Stock Upgrades & Downgrades: Alcatel Lucent (NYSE:ALU), Luxottica Group ...  Property Mentor
Related articles »  
GlaxoSmithKline (GSK) Tops Access To Medicine Index
GlaxoSmithKline plc (ADR) (NYSE:GSK) topped the 2014 Access to Medicines Index, which measures the efforts made by pharmaceutical companies to enhance access to various medicines in developing countries.
Buzz Stocks: GlaxoSmithKline plc (ADR), Valeant Pharmaceuticals Intl Inc, and ...
Futures are pointed higher this morning, ahead of the Federal Open Market Committee's (FOMC) latest meeting minutes and the unofficial start of earnings season.
Related articles »  
Keys To Investing In A Bull Market [GlaxoSmithKline plc (ADR), Facebook Inc]
bearbull2 Chad Shoop: U.S. stocks are still very much in a bull market - just one with increasing volatility. In October, stocks suffered the sharpest drop since 2011, and then rebounded just as rapidly to close the month at, or near, all-time highs ...
Related articles »  
Ebola Contracts Worth $2 Billion To Benefit Pharma Companies
Drug makers such as Mapp Biopharmaceuticals, Johnson & Johnson (JNJ), and GlaxoSmithKline plc (ADR) (GSK) could gain from what could potentially be $2 billion worth of Ebola-related contracts.
Related articles »  
Veteran Blames Doctors Without Borders For Delay In Ebola Vaccines
The most advanced of these is GlaxoSmithKline plc's (ADR) (NYSE:GSK) anti-flu vaccine, which is currently being tested in two separate trials in the UK and US.
Related articles »  
Johnson & Johnson Joins Hands With GSK To Fight Ebola
Johnson & Johnson (JNJ) and GlaxoSmithKline plc (ADR) (GSK), two of the biggest pharmaceuticals working on an Ebola treatment, are looking to collaborate to speed up the developmental process and provide a cure to the millions threatened by the Ebola ...
Related articles »  
Morning Buzz: Ligand Pharmaceuticals Inc. (NASDAQ:LGND), GlaxoSmithKline ...
Ligand Pharmaceuticals Inc. (NASDAQ:LGND) said its partner GlaxoSmithKline plc (ADR) (NYSE:GSK) submitted a request to European regulators to expand the marketing of Revolade, its product to treat adult patients with severe aplastic anemia (SAA) who ...
Related articles »  
Ebola Softens In Liberia
GlaxoSmithKline plc (ADR) (GSK), NewLink Genetics Corp (NLNK), and Johnson & Johnson (JNJ) are topping the list of companies developing Ebola vaccines.
Related articles »